H. Pourhassan

发表

Lack of association between FTO gene variations and metabolic healthy obese (MHO) phenotype: Tehran Cardio-metabolic Genetic Study (TCGS)

F. Azizi, M. Daneshpour, M. Barzin, 2018, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

Signaling pathways in medullary thyroid carcinoma: therapeutic implications

M. Hedayati, Zahra Nozhat, H. Pourhassan, 2016 .

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

I. Aldoss, J. Zaia, S. Forman, 2022, Blood Advances.

Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML).

G. Marcucci, I. Aldoss, P. Curtin, 2022, Leukemia & lymphoma.

Asparaginase: How to Better Manage Toxicities in Adults

I. Aldoss, D. Douer, V. Pullarkat, 2022, Current Oncology Reports.

SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALL.

I. Aldoss, D. Douer, H. Pourhassan, 2022, Clinical lymphoma, myeloma & leukemia.

Post-transplant sinusoidal obstruction syndrome in adult patients with B-cell Acute Lymphoblastic Leukemia treated with pre-transplant Inotuzumab.

G. Marcucci, I. Aldoss, P. Curtin, 2023, Transplantation and cellular therapy.

Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

J. Wong, H. Mirshahidi, B. Schaeffer, 2019, Experimental Hematology & Oncology.

Cell Type-Specific Induction and Inhibition of Apoptosis by Herpes Simplex Virus Type 2 ICP10

K. Jerome, Jin-Young Han, S. Miller, 2008, Journal of Virology.

Cell Type-Specific Induction and Inhibition of Apoptosis by Herpes Simplex Virus Type 2 ICP 10

K. Jerome, Jin-Young Han, S. Miller, 2008 .

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

N. Bejanyan, C. Ustun, C. Brunstein, 2016, Bone Marrow Transplantation.

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions

G. Marcucci, I. Aldoss, P. Curtin, 2023, American journal of hematology.

Tocilizumab for Cytokine Release Syndrome Management after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

G. Marcucci, I. Aldoss, P. Curtin, 2023, Transplantation and cellular therapy.